- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
- 10 Jun 20 QUALIF Notice of qualification
- 29 May 20 1-A POS Offering $50M in Equity
- 20 May 20 1-A POS Offering $50M in Equity
-
1 May 20 1-A POS Offering $50M in Equity
- 30 Aug 19 253G2 Offering circular supplement
- 19 Aug 19 253G2 Offering circular supplement
- 19 Aug 19 1-U/A Current report (pursuant to Regulation A) (amended)
- 19 Aug 19 253G2 Offering circular supplement
- 17 Apr 19 QUALIF Notice of qualification
- 9 Apr 19 1-A/A Offering $50M in Equity
- 9 Apr 19 1-A/A Offering $50M in Equity
- 27 Mar 19 1-A/A Offering $50M in Equity
- 5 Mar 19 1-A/A Offering $50M in Equity
- 17 Dec 18 1-A/A Offering $50M in Equity
- 10 Dec 18 1-A Offering $50M in Equity
D y l a n F l o y d A c c o u n t i n g & C o n s u l t i n g
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use in the Pos-Qualification Amendment No.1 to Offering Circular constituting an amendment the Offering Statement on Form 1-A, previously filed on April 9, 2019 and qualified on April 16, 2019, as amended, of our Independent Auditor’s Report dated April 28, 2020 relating to the balance sheet of Cannabinoid Biosciences, Inc. as of December 31, 2019, and the related statements of operations, changes in members’ equity (deficit), and cash flows for the period from May 6, 2014 (inception) to December 31, 2019, and the related notes to the financial statements.
Albert Garcia, CPA
DylanFloyd Accounting & Consulting
April 28, 2020
Newhall CA